These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 9781341)
1. Structural and immunochemical studies on bovine lactoferrin fragments. Shimazaki K; Kamio M; Nam MS; Harakawa S; Tanaka T; Omata Y; Saito A; Kumura H; Mikawa K; Igarashi I; Suzuki N Adv Exp Med Biol; 1998; 443():41-8. PubMed ID: 9781341 [No Abstract] [Full Text] [Related]
2. Monoclonal antibody against bovine Lactoferricin and its epitopic site. Shimazaki K; Nam MS; Harakawa S; Tanaka T; Omata Y; Saito A; Kumura H; Mikawa K; Igarashi I; Suzuki N J Vet Med Sci; 1996 Dec; 58(12):1227-9. PubMed ID: 8996707 [TBL] [Abstract][Full Text] [Related]
3. Characterization of monoclonal antibodies against human lactoferrin. van Berkel PH; van Veen HA; Geerts ME; Nuijens JH J Immunol Methods; 2002 Sep; 267(2):139-50. PubMed ID: 12165435 [TBL] [Abstract][Full Text] [Related]
4. Non-reducing terminal fucose within N-linked glycan plays a significant role in the recognition of human milk lactoferrin by the 1CF11 monoclonal antibody. Fukaya S; Yabe T; Kanamaru Y Biosci Biotechnol Biochem; 2010; 74(10):2141-4. PubMed ID: 20944405 [TBL] [Abstract][Full Text] [Related]
5. Lactoferrampin: a novel antimicrobial peptide in the N1-domain of bovine lactoferrin. van der Kraan MI; Groenink J; Nazmi K; Veerman EC; Bolscher JG; Nieuw Amerongen AV Peptides; 2004 Feb; 25(2):177-83. PubMed ID: 15062998 [TBL] [Abstract][Full Text] [Related]
6. Tyrosine- versus serine-phosphorylation leads to conformational changes in a synthetic tau peptide. Fabian H; Otvos L; Szendrei GI; Lang E; Mantsch HH J Biomol Struct Dyn; 1994 Dec; 12(3):573-9. PubMed ID: 7537044 [TBL] [Abstract][Full Text] [Related]
7. Identification of the bactericidal domain of lactoferrin. Bellamy W; Takase M; Yamauchi K; Wakabayashi H; Kawase K; Tomita M Biochim Biophys Acta; 1992 May; 1121(1-2):130-6. PubMed ID: 1599934 [TBL] [Abstract][Full Text] [Related]
8. Properties of a heparin-binding peptide derived from bovine lactoferrin. Shimazaki K; Tazume T; Uji K; Tanaka M; Kumura H; Mikawa K; Shimo-Oka T J Dairy Sci; 1998 Nov; 81(11):2841-9. PubMed ID: 9839225 [TBL] [Abstract][Full Text] [Related]
9. A peptide domain of bovine milk lactoferrin inhibits the interaction between streptococcal surface protein antigen and a salivary agglutinin peptide domain. Oho T; Bikker FJ; Nieuw Amerongen AV; Groenink J Infect Immun; 2004 Oct; 72(10):6181-4. PubMed ID: 15385529 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the protein and glycan moieties in different forms of bovine lactoferrin. Ye XY; Nishimura T; Yoshida S Biosci Biotechnol Biochem; 1997 May; 61(5):782-6. PubMed ID: 9178553 [TBL] [Abstract][Full Text] [Related]
11. Conformational requirements for molecular recognition of acetylcholine receptor main immunogenic region (MIR) analogues by monoclonal anti-MIR antibody: a two-dimensional nuclear magnetic resonance and molecular dynamics approach. Tsikaris V; Detsikas E; Sakarellos-Daitsiotis M; Sakarellos C; Vatzaki E; Tzartos SJ; Marraud M; Cung MT Biopolymers; 1993 Jul; 33(7):1123-34. PubMed ID: 8343589 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of iron/ascorbate-induced lipid peroxidation by an N-terminal peptide of bovine lactoferrin and its acylated derivatives. Wakabayashi H; Matsumoto H; Hashimoto K; Teraguchi S; Takase M; Hayasawa H Biosci Biotechnol Biochem; 1999 May; 63(5):955-7. PubMed ID: 10380640 [TBL] [Abstract][Full Text] [Related]
13. Unique epitopes of lactoferrin expressed in human cytotrophoblasts involved in immunologic reactions. Thaler CJ; Labarrere CA; Hunt JS; McIntyre JA; Faulk WP Am J Obstet Gynecol; 1999 Aug; 181(2):460-7. PubMed ID: 10454701 [TBL] [Abstract][Full Text] [Related]
15. Immunogenic properties of an anti-DNA antibody-derived peptide, 88H.64-80: location of a dominant idiotope defined by T and B cells. Ward FJ; Khan N; Wolger LJ; Howe CA; Eivazova ER; Harper N; Muller S; Staines NA J Autoimmun; 1998 Oct; 11(5):439-47. PubMed ID: 9802927 [TBL] [Abstract][Full Text] [Related]
16. Effect of trypsin on bovine lactoferrin and interaction between the fragments under different conditions. Mata L; Castillo H; Sánchez L; Puyol P; Calvo M J Dairy Res; 1994 Aug; 61(3):427-32. PubMed ID: 7962841 [No Abstract] [Full Text] [Related]
17. Distinct bactericidal activities of bovine lactoferrin peptides LFampin 268-284 and LFampin 265-284: Asp-Leu-Ile makes a difference. van der Kraan MI; Nazmi K; van 't Hof W; Amerongen AV; Veerman EC; Bolscher JG Biochem Cell Biol; 2006 Jun; 84(3):358-62. PubMed ID: 16936807 [TBL] [Abstract][Full Text] [Related]
18. Involvement of both the N-glycan-relevant and N-glycan-irrelevant structural elements in the recognition of human milk lactoferrin by the 1CF11 monoclonal antibody. Fukaya S; Shinoda C; Yabe T; Kanamaru Y Biosci Biotechnol Biochem; 2010; 74(10):2127-9. PubMed ID: 20944410 [TBL] [Abstract][Full Text] [Related]
19. Direct detection and quantitative determination of bovine lactoferricin and lactoferrin fragments in human gastric contents by affinity mass spectrometry. Kuwata H; Yip TT; Yip CL; Tomita M; Hutchens TW Adv Exp Med Biol; 1998; 443():23-32. PubMed ID: 9781339 [TBL] [Abstract][Full Text] [Related]
20. Presence of a glycan at a potential N-glycosylation site, Asn-281, of bovine lactoferrin. Wei Z; Nishimura T; Yoshida S J Dairy Sci; 2000 Apr; 83(4):683-9. PubMed ID: 10791783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]